Abaxis Inc (ABAX.O)
ABAX.O on Nasdaq
40.96USD
1 Aug 2013
40.96USD
1 Aug 2013
Price Change (% chg)
$-1.14 (-2.71%)
$-1.14 (-2.71%)
Prev Close
$42.10
$42.10
Open
$41.96
$41.96
Day's High
$42.18
$42.18
Day's Low
$40.72
$40.72
Volume
242,272
242,272
Avg. Vol
134,213
134,213
52-wk High
$51.84
$51.84
52-wk Low
$33.28
$33.28
About
Abaxis, Inc. develops portable multitest analyzer based on established principles of centrifugal analysis. Product will allow complete blood chemical constituent measurements to be done instantly in the patient care setting.
Overall
| Beta: | 0.97 |
| Market Cap (Mil.): | $938.11 |
| Shares Outstanding (Mil.): | 22.28 |
| Dividend: | 1.00 |
| Yield (%): | -- |
Financials
| ABAX.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 33.91 | 27.50 | 37.76 |
| EPS (TTM): | 1.24 | -- | -- |
| ROI: | 15.71 | 9.26 | 18.76 |
| ROE: | 16.18 | 12.54 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| IDEXX Laboratories, Inc. (IDXX.OQ) | $99.19 | +1.20 |
| Heska Corp (HSKA.OQ) | $6.88 | -0.07 |
| Alere Inc (ALR.N) | $34.16 | +0.76 |
| Alere Inc (ALR_pb.N) | $277.30 | +0.29 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$49.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

